Risk of Ovarian Cancer in Patients With a Pelvic Mass

Completed

Conditions studied: Ovarian Cancer

In brief

The purpose of this clinical trial is to evaluate the ability of multiple serum biomarkers to estimate the risk of ovarian cancer in women presenting with pelvic mass (defined as a simple, complex or a solid ovarian cyst / pelvic mass).

Key facts

Study ID

NCT00315692

Run by

Fujirebio Diagnostics, Inc.

People needed

566

Starts

2005-12-01

Expected to finish

2007-02-01

Last updated by the study team

2011-11-08

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Females selected to undergo laparotomy or laparoscopy based on a finding of pelvic mass (defined as a simple, complex or a solid ovarian cyst / pelvic mass);
• Pre- and post-menopausal women greater than or equal to 18 years of age;
• Pelvic mass must be demonstrated by ultrasound
• Able to understand and sign Informed Consent

You may not qualify if…

• Treatment for any malignancy (with the exception of non-melanoma skin cancer) within the last five years
• Subjects receiving cytotoxic chemotherapies, such as cyclophosphamide or methotrexate
• Subjects with previous bilateral oophorectomy
• Any subject known to be pregnant

Where it is running

• Fujirebio Diagnostics, Inc — Malvern, Pennsylvania, United States
• Richard Moore — Providence, Rhode Island, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.